title: Re: James J. Hsieh, David Chen, Patricia I. Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14.
authors.affiliation: Department of Urology, Xiangya Hospital, Central South University, Changsha, P.R. China.
authors.forename: Ye
authors.initials: Y
authors.lastname: Lei
authors.affiliation: Department of Urology, Diakonie Klinikum Stuttgart, Stuttgart, Germany.
authors.forename: Serdar
authors.initials: S
authors.lastname: Yildiz
authors.affiliation: Department of Urology, Xiangya Hospital, Central South University, Changsha, P.R. China. Electronic address: minfengchen1234@163.com.
authors.forename: Minfeng
authors.initials: M
authors.lastname: Chen
mesh_terms: D015415:Biomarkers; D002292:Carcinoma, Renal Cell; D000068338:Everolimus; D023281:Genomics; D006801:Humans; D007211:Indoles; D007680:Kidney Neoplasms; D011758:Pyrroles; D000077210:Sunitinib
chemical_list: D015415:Biomarkers; D007211:Indoles; D011758:Pyrroles; D000068338:Everolimus; D000077210:Sunitinib